541 related articles for article (PubMed ID: 17728232)
21. Transmission of HIV-1 CTL escape variants provides HLA-mismatched recipients with a survival advantage.
Chopera DR; Woodman Z; Mlisana K; Mlotshwa M; Martin DP; Seoighe C; Treurnicht F; de Rosa DA; Hide W; Karim SA; Gray CM; Williamson C;
PLoS Pathog; 2008 Mar; 4(3):e1000033. PubMed ID: 18369479
[TBL] [Abstract][Full Text] [Related]
22. Selection, transmission, and reversion of an antigen-processing cytotoxic T-lymphocyte escape mutation in human immunodeficiency virus type 1 infection.
Allen TM; Altfeld M; Yu XG; O'Sullivan KM; Lichterfeld M; Le Gall S; John M; Mothe BR; Lee PK; Kalife ET; Cohen DE; Freedberg KA; Strick DA; Johnston MN; Sette A; Rosenberg ES; Mallal SA; Goulder PJ; Brander C; Walker BD
J Virol; 2004 Jul; 78(13):7069-78. PubMed ID: 15194783
[TBL] [Abstract][Full Text] [Related]
23. Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
Matsuoka S; Dam E; Lecossier D; Clavel F; Hance AJ
Retrovirology; 2009 Mar; 6():21. PubMed ID: 19254360
[TBL] [Abstract][Full Text] [Related]
24. Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
Brander C; Yang OO; Jones NG; Lee Y; Goulder P; Johnson RP; Trocha A; Colbert D; Hay C; Buchbinder S; Bergmann CC; Zweerink HJ; Wolinsky S; Blattner WA; Kalams SA; Walker BD
J Virol; 1999 Dec; 73(12):10191-8. PubMed ID: 10559335
[TBL] [Abstract][Full Text] [Related]
25. Multilayered defense in HLA-B51-associated HIV viral control.
Zhang Y; Peng Y; Yan H; Xu K; Saito M; Wu H; Chen X; Ranasinghe S; Kuse N; Powell T; Zhao Y; Li W; Zhang X; Feng X; Li N; Leligdowicz A; Xu X; John M; Takiguchi M; McMichael A; Rowland-Jones S; Dong T
J Immunol; 2011 Jul; 187(2):684-91. PubMed ID: 21670313
[TBL] [Abstract][Full Text] [Related]
26. Marked epitope- and allele-specific differences in rates of mutation in human immunodeficiency type 1 (HIV-1) Gag, Pol, and Nef cytotoxic T-lymphocyte epitopes in acute/early HIV-1 infection.
Brumme ZL; Brumme CJ; Carlson J; Streeck H; John M; Eichbaum Q; Block BL; Baker B; Kadie C; Markowitz M; Jessen H; Kelleher AD; Rosenberg E; Kaldor J; Yuki Y; Carrington M; Allen TM; Mallal S; Altfeld M; Heckerman D; Walker BD
J Virol; 2008 Sep; 82(18):9216-27. PubMed ID: 18614631
[TBL] [Abstract][Full Text] [Related]
27. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
[TBL] [Abstract][Full Text] [Related]
28. Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
Schneidewind A; Brockman MA; Sidney J; Wang YE; Chen H; Suscovich TJ; Li B; Adam RI; Allgaier RL; Mothé BR; Kuntzen T; Oniangue-Ndza C; Trocha A; Yu XG; Brander C; Sette A; Walker BD; Allen TM
J Virol; 2008 Jun; 82(11):5594-605. PubMed ID: 18385228
[TBL] [Abstract][Full Text] [Related]
29. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
[TBL] [Abstract][Full Text] [Related]
30. Accumulation of Pol Mutations Selected by HLA-B*52:01-C*12:02 Protective Haplotype-Restricted Cytotoxic T Lymphocytes Causes Low Plasma Viral Load Due to Low Viral Fitness of Mutant Viruses.
Murakoshi H; Koyanagi M; Chikata T; Rahman MA; Kuse N; Sakai K; Gatanaga H; Oka S; Takiguchi M
J Virol; 2017 Feb; 91(4):. PubMed ID: 27903797
[TBL] [Abstract][Full Text] [Related]
31. Impaired replication capacity of acute/early viruses in persons who become HIV controllers.
Miura T; Brumme ZL; Brockman MA; Rosato P; Sela J; Brumme CJ; Pereyra F; Kaufmann DE; Trocha A; Block BL; Daar ES; Connick E; Jessen H; Kelleher AD; Rosenberg E; Markowitz M; Schafer K; Vaida F; Iwamoto A; Little S; Walker BD
J Virol; 2010 Aug; 84(15):7581-91. PubMed ID: 20504921
[TBL] [Abstract][Full Text] [Related]
32. Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H; Akahoshi T; Koyanagi M; Chikata T; Naruto T; Maruyama R; Tamura Y; Ishizuka N; Gatanaga H; Oka S; Takiguchi M
J Virol; 2015 May; 89(10):5330-9. PubMed ID: 25741000
[TBL] [Abstract][Full Text] [Related]
33. HLA-A*7401-mediated control of HIV viremia is independent of its linkage disequilibrium with HLA-B*5703.
Matthews PC; Adland E; Listgarten J; Leslie A; Mkhwanazi N; Carlson JM; Harndahl M; Stryhn A; Payne RP; Ogwu A; Huang KH; Frater J; Paioni P; Kloverpris H; Jooste P; Goedhals D; van Vuuren C; Steyn D; Riddell L; Chen F; Luzzi G; Balachandran T; Ndung'u T; Buus S; Carrington M; Shapiro R; Heckerman D; Goulder PJ
J Immunol; 2011 May; 186(10):5675-86. PubMed ID: 21498667
[TBL] [Abstract][Full Text] [Related]
34. Compensatory mutations restore the replication defects caused by cytotoxic T lymphocyte escape mutations in hepatitis C virus polymerase.
Oniangue-Ndza C; Kuntzen T; Kemper M; Berical A; Wang YE; Neumann-Haefelin C; Foote PK; Hills-Evans K; Reyor LL; Kane K; Gladden AD; Bloom AK; Power KA; Thimme R; Lauer GM; Henn MR; Kim AY; Allen TM
J Virol; 2011 Nov; 85(22):11883-90. PubMed ID: 21880756
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response.
Feeney ME; Tang Y; Pfafferott K; Roosevelt KA; Draenert R; Trocha A; Yu XG; Verrill C; Allen T; Moore C; Mallal S; Burchett S; McIntosh K; Pelton SI; St John MA; Hazra R; Klenerman P; Altfeld M; Walker BD; Goulder PJ
J Immunol; 2005 Jun; 174(12):7524-30. PubMed ID: 15944251
[TBL] [Abstract][Full Text] [Related]
36. Viral evolution in HLA-B27-restricted CTL epitopes in human immunodeficiency virus type 1-infected individuals.
Setiawan LC; Gijsbers EF; van Nuenen AC; Kootstra NA
J Gen Virol; 2015 Aug; 96(8):2372-2380. PubMed ID: 25872744
[TBL] [Abstract][Full Text] [Related]
37. Novel cytotoxic T-lymphocyte escape mutation by a three-amino-acid insertion in the human immunodeficiency virus type 1 p6Pol and p6Gag late domain associated with drug resistance.
Cao J; McNevin J; McSweyn M; Liu Y; Mullins JI; McElrath MJ
J Virol; 2008 Jan; 82(1):495-502. PubMed ID: 17942528
[TBL] [Abstract][Full Text] [Related]
38. Immune selection for altered antigen processing leads to cytotoxic T lymphocyte escape in chronic HIV-1 infection.
Draenert R; Le Gall S; Pfafferott KJ; Leslie AJ; Chetty P; Brander C; Holmes EC; Chang SC; Feeney ME; Addo MM; Ruiz L; Ramduth D; Jeena P; Altfeld M; Thomas S; Tang Y; Verrill CL; Dixon C; Prado JG; Kiepiela P; Martinez-Picado J; Walker BD; Goulder PJ
J Exp Med; 2004 Apr; 199(7):905-15. PubMed ID: 15067030
[TBL] [Abstract][Full Text] [Related]
39. CTL escape mediated by proteasomal destruction of an HIV-1 cryptic epitope.
Cardinaud S; Consiglieri G; Bouziat R; Urrutia A; Graff-Dubois S; Fourati S; Malet I; Guergnon J; Guihot A; Katlama C; Autran B; van Endert P; Lemonnier FA; Appay V; Schwartz O; Kloetzel PM; Moris A
PLoS Pathog; 2011 May; 7(5):e1002049. PubMed ID: 21589903
[TBL] [Abstract][Full Text] [Related]
40. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
